Phase 1- Solution Design
This Phase has been completed.
The summaries of the Solution Designs can be viewed here
Duration: 16th April to 16th October 2022
During Phase 1 the Contractors will perform research to:
- elaborate the solution design and determine the approach to be taken to develop the new solutions and
- demonstrate the technical, financial and commercial feasibility of the proposed concepts and approach to meet the procurement need.
Phase 1 Awards
Budget of awarded contracts: 610 246.65 EUR
Tenders received: 24
Number of Contracts awarded: 15
Lot 1: Pre-Sequencing: 5
Lot 2: Sequencing: Due to the insufficient number of tenders received, no contract has been awarded in Lot 2.
Lot 3: Bioinformatics Analysis: 5
Lot 4: Integrated Reporting: 5
Selected tenders:
Lot 1: Pre Sequencing
Agilent-Technologies-Instand-NGS4P-Lot 1 – Project abstract
Lead: Agilent Technologies R&D Marketing GmbH & Co KG
IDT – Project abstract
Lead: Integrated DNA Technologies, BV
Trinity- Project abstract
Lead: QIAGEN GmbH
Thermo Fisher Scientific 1-Day NGS – Project abstract
Lead: Thermo Fisher Scientific 1-Day NGS
TwistPlatomicsMGI – Project abstract
Lead: Twist Bioscience Corporation
Lot 3: Bioinformatics Analysis
EU Onco-Platform L3 – Project abstract
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
Congenica L3 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
Consortium members: Single tenderer
Cancer Analysis GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
Consortium members: Single tenderer
INSPECT – Project abstract
Lead: Phenosystems SA
Lead: Phenosystems SA
Consortium members: Maxeler Technologies Ltd., Haute école spécialisée de Suisse occidentale
PlatoDKFZCharité – Project abstract
Lead: Platomics GmbH
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
Lot 4: Integrated Reporting
EU Onco Platform L4 – Project abstract
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
Congenica L4 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
Consortium members: Single tenderer
tde4ngs – Project abstract
Lead: fragmentiX Storage Solutions GmbH
Consortium members: ID GmbH & Co. KgaA, Maxeler Technologies Ltd., Prime Force GmbH
Cancer Reporting GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
VRSM – Project abstract
Lead: Saphetor SA
Consortium members: Single tenderer